A priori paradoxical, the number of circulating CD4+ TFH cells, which likely reflects the type of TFH cells infiltrating tumours, appears to be significantly increased in DLBCL cases, especially in more advanced stages of the disease [84]. The gene discussed is CD4; the disease is diffuse large B-cell lymphoma.